healthcare the process of innovation - comb.cat · is provided through bluetooth devices that...
TRANSCRIPT
MUCORTODONT Dra. Xxxxx Xxxx – Medial device protector de mucosa pels ortodoncistes
GALENIA Dra. Xxxxx Xxxx – Portal informació sanitària
DAGDr. Xxxxx Xxxx – Clíniques Atenció Primària col·lectiu Alemania
NEWEYESDr. Xxxxx Xxxx –Tractament de la presbícia amb làser
O+Sr. Xxxxx Xxxx –Avisador presa fàrmacs
Wi-GDra. Xxxxx Xxxx – TI
GeriatDra. Xxxxx Xxxx – Centres Geriàtrics
DISPOSITIU EN DELTADr. Xxxxx Xxxx – MedicalDevice cirurgia ortopèdica
WDMP Sra. Xxxxx Xxxx –Monitorització a distancia patologies cròniques
PDU Dr. Xxxxx Xxxx –Unitats de diagnòstic incontinència
VISUAL CORDr. Xxxxx Xxxx – Software de gestió en cardiologia
UTD Dra. Xxxxx Xxxx – Unitats de tractament integral dermatològic
ERA BIOTECHSr. Xxxxx Xxxx – Enablingtechnology biotech produccióproteica facilitada
IRCDr. Xxxxx Xxxx – Institut de Rehabilitació Cerebral
IMPODr. Xxxxx Xxxx – IT informació mèdica personal online
NEUROSCIENCE TECHNOLOGIESDr. Xxxxx Xxxx – Suport a la indústria en investigacióbàsica
PIGPAP Dr. Xxxxx Xxxx – Software gestió consultes
TM Dr. Xxxxx Xxxx – Sistemes telemedicina
CITOGYN Dr. Xxxxx Xxxx – Medicaldevice citologia cervix
DIGMO Dr. Xxxxx Xxxx – Medicaldevice medició estrabismeSALTBAG
Dr. Xxxxx Xxxx –Dispensador de sal per malalts amb HTA
CITOGYN Sr. Xxxxx Xxxx– Medicalliterature en castellà
IDEA OPPORTUNITY VALUE VC Start-up
NUCLEOTIDEDr. Xxxxx Xxxx – Uso nucleotidos en leches y nutricion en general
AMB-PATDr. Xxxxx Xxxx
SEPARADOR URO Dr. Xxxxx Xxxx
SOFT GEST CAPS Dr. Xxxxx Xxxx
RFID Sr. XxxxxXxxx –Control congressos
Medical G. Xxxxx–Dispositiu Control Diabetics
Psiqu OnlineSr. Xxxxx Xxxx – Eina formació col·lectius
HomeovisionDra. Xxxxx Xxxx
Stop PEE-PEEDr. xxxxxx – Medical Deviceincontinencia urinaria
Odonto movilDra. xxxxx – Modelo negocio servicio
Reactivos diagDra. xxxxx – Medical Devicetubos analisis automáticomicroorganismos
CANULA TUMOR Dr. xxxxxxxxxxxx –Medical Device cirugía
Instituto columna Dr. Xxxxxxxxxxxxxx –Modelo negocio servicios
VACCSAC Dr. Xxxxx Xxxx –Eco vascular
ESTETODONTO Dr. Xxxxx Xxxx –Estetica en odonto
MULTIFEV Dr. Xxxxx Xxxx –DIagnost neumo
SINCRON Dr. Xxxxx Xxxx –Errores pharma
Auto-test screenerA start-up has recently designed a “simple to use”, safe and efficient medical device allowing women to “auto-perform” a cervix cancer screening at home, without the inconveniences of the classical gynecological exploration.
The problem:% of women participating in cervix cancer screenings is low.
Sector: Medical Devices
Enabling TechnologyA start-up has designed “storage organelles”, a “disruptive”technology allowing to produce and purify proteins in a more efficient way. Their new technology has enabled the production of difficult-to-express proteins with (1) significant cost reductions and (2) increased efficiency, selling the technology to pharma and biotech companies.
The problem:Producing proteins is an expensive and time consuming activity.
Sector: Life Sciences
Retail healthcareA start-up developed a new “medical clinic” concept, a small space offering medical attention for minor conditions in malls and other high traffic areas at a low cost (50$ average visit) and with no waiting time. The first clinic started 5 years ago. Today there are more than 700 clinics in the US.
The problem:“Baby boomers” have no time to go to the doctor for minor conditions.
Sector: Services
Wireless disease managementSeveral initiatives are offering a very convenient medical control of chronic diseases such as diabetes, hypertension, asthma, etc., allowing patients to reduce significantly the number of visits to their GPs. Control is provided through bluetooth devices that monitor different conditions and transmit medical data through regular mobile phones.
The problem:Chronic conditions require multiple visits (most of them unnecessary) making patients lives very uncomfortable.
Sector: IT
It is important to know the healthcare sector
#2
• Healthcare value chain is the instrument to know all stakeholders
•It is essential as well to know the 4 areas of healthcareinnovation, they usually interact.
Consumer, prescriber and payerThree different stakeholders, each one of them worried by differentissues
Consumer
Prescriber
Payer
A heavily regulated marketplace
In the last years, healthcare has witnessed the emergenceof an increasing regulatory environment throughout theworld. This environment has an impact on how productsand services are tested on patients, and how they get approved.
Big compaies wantto buy innovation, R+D is becomingR+A
Trends
Elderly peopleon the rise
Large amountof clinical
needsunderserved
Active, more mobilethan previousgenerations
Opportunities in all 4 sectors
Qualitativetechnological
breakthroughs
Moreefficientchannels
Consolidationas something
good for start-ups
Healthcare Sector
Is it an opportunity?
#4
Good idea = Opportunity
We need to learn to recognise an opportunity from a goodidea.
Sustainable business
model
Qualified team
Strong IP / BE Large
market
Great product
Smooth path to market
Perfect
The perfect initiative
PROTECTION AGREEMENTS
•Non-disclosure
•Non-compete
COMMON SHARES
•Tag-along right
•Pre-emptive right
•Registration rights
PREFERRED SHARES
•Royalty rights
•Dividend rights
•Registration rights
•Board rights
•Information rights
•Liquidation rights
•Conversion rights
•Redemption rights
CONVERSIONS
•Price conversion
•Future price conversion
•Interest payments
WARRANTIES
•Warranties andrepresentations
•Anti-dilution
•Entrepreneur compensationlimits
•Special voting or consentrights
•Warrants
•Follow-on financings
•Right of first refusal
ANALYSIS
•Exit impact
•Relationship impact
•Downside protection
•Upside protection
•Entrepreneur protection
•Worst case scenarios
•Notes and suggestions
DEAL STRUCTURE
INTRAPRE NEURSHIP
EXECUTION
All levels, MDs, healthcare professionals
Identify opportunities
Clinician buy-in
VC, technology transfer, government, hospitals, universities, research institutes…
Benchmark innovative practices outside
Training CULTURE
DETECTION
BENCH MARKING
ECOSISTEM
Encourage entrepreneurial culture
Technology transfer
Implementation and follow-up
Generate portfolio projects
Promote generated innovation Attract new value
generators
All sectors, life sciences, medical devices, services
Calculate operative impact and €
Generate “rules of the game”
Generate spin-offs
Adapt external ideas
Best practices
Define process
Use same criteria as venture capital to follow execution
Incentivatedialog and risks
INNOVATION
LIFE SCIENCES INNOVATION ECOSYSTEM
BMA
Business schools
ESADE
IESE
EADA
Support
Dealflow
Venture capital
Innova 31
SofinnovaRiva y Garcia
Co-inversió
Dealflow
Gov
Bioregion
CIDEM
Business angels
BANCAT
Keiretsu Forum
Research Institutes
•IMIM / H.del Mar
•IDIBAPS / H. Clínic
•IDIBELL/ H Bellvitge
Incubation start-ups
Fund managers
GFCRs
XPCAT
IESE, ESADE, UPC
UAB, UB, UG, Salle
Partner financer
MultiM
ulti
Hospitals
Gilde
Highgrowth
•H Sant Pau
•H. Vall d´Hebron
•H Badalona
•Parc recercabiomed
•etc…
CorsabeLa Caixa CR
Biofocus
HSJDM.D.s
AltaPartners